“How many millionaires do you know who have become wealthy by investing in savings accounts? I rest my case.”

— Robert G. Allen

Jeff Bishop

Betting on SNPX

Betting on SNPX

      Sponsored By       Hello again, Trader! Yes, I’ve been talking a lot about Synaptogenix (SNPX) lately, and yes, I know the trading has been disappointing to say the least the last few days. In times like this when the market tests...

This Biotech company caught my eye

This Biotech company caught my eye

  Sponsored by:     If you’ve been following our updates, you know that MYMD-1® seeks to target the CAUSE, not just the symptoms, that drive autoimmunity and inflammation. However, did you also know that MYMD-1® may behave like an ANTIDEPRESSANT? This...

RYSE and Shine!

RYSE and Shine!

      Sponsored By:  Want to invest in the next big brand name in your home and get in on the ground floor of an innovative technology company? Meet RYSE. RYSE is the first retrofit solution to motorize and automate installed window blinds and shades,...

Could a cure be around the corner 🤔

Could a cure be around the corner 🤔

      Sponsored By         Do you know someone suffering from Alzheimer’s or has lost their fight with it? It’s likely you do, as 1 in 3 seniors dies with Alzheimer's (AD) or another dementia -- which kill more than breast cancer and...

MyMD battling brain-related disorders – let’s gooooo

MyMD battling brain-related disorders – let’s gooooo

    Sponsored By Recently we’ve been following the story of MyMD, particularly in regard to its lead drug indication – MYMD-1® – in Phase 2 trials for sarcopenia (aka aging).  But what led MyMD to pursue this path? As all companies have limited resources,...

Injection, infusion or pill…hmmm🤔

Injection, infusion or pill…hmmm🤔

  Sponsored By Hello Traders-Jeff Bishop Here! If you’ve been following our updates about MyMD, you know we’ve been focusing primarily on MYMD-1® and its Phase 2 trial as a therapy for delaying aging and prolonging healthy lifespan.  To do this, MYMD-1® is...

Scientists Are Obsessed with THESE TWO Questions

Scientists Are Obsessed with THESE TWO Questions

  Sponsored By Greetings Traders, “What causes a person’s body to attack itself?” and “Why is a particular tissue selected as the target?” Although these questions have completely stumped scientists, what happens to the body has not.  Autoimmune diseases wreak...

This stock needs to be on your radar, again

This stock needs to be on your radar, again

  Sponsored By See Disclosure Below Take note, Trader! It has been over a week since I talked about MYMD. As you know, I have been bullish on MyMD for some time now. Why should you care about this tiny biotech stock? For starters, I think that anyone 40 years...

MYMD on FOX

MYMD on FOX

  Sponsored by MYMD See Disclosure Below Hello, I hope you have been paying attention to what has been happening with MYMD lately?   It is the very first company that we have chosen to work with directly and share with our audience.   As you can imagine, I get a...

MyMD Squeeze Play? Check it out!

MyMD Squeeze Play? Check it out!

  Sponsored by:     Is a squeeze coming on MYMD soon? Let’s dig in. ⛏ In 360 Wall Street, we do a lot of momentum trading.  One of the big things we look for is positively stacked EMAs. (Exponential Moving Averages) Momentum tends to play out over a few...